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Abstract

Materials and Methods

T cell Activation Markers

Periodontal disease is a chronic inflammatory oral disease initiated by P. gingivalis, a
gram-negative bacterium, within the periodontal pockets that surround teeth. CD4+ T
helper cells (Th) play a key role in the oral adaptive immune response. However,
hyperactive Th cells produce inflammatory cytokines that accelerate alveolar bone loss
and soft tissue damage. CD5 is a coreceptor found on T cells that inhibits T cell
activation and limits effector function. We hypothesize that CD5 knockout (CD5KO) T
cells have increased activation and effector function compared to wildtype when
exposed to P. gingivalis LPS and that CD5 is a potential drug target to reduce
inflammation in periodontitis. Using flow cytometry, we observed an increase in early
and late T cell activation markers (CD25 and CD69) in CD5KO T cells co-cultured with
gingival or oral mucosal epithelial cells stimulated with P. gingivalis LPS. We also
analyzed the gene transcription and protein expression of key cytokines from T cells
that contribute to inflammation and alveolar bone loss using RT-qPCR and ELISpot
analysis. Our results demonstrate that CD5 plays a prominent role in periodontal
disease. This research will provide valuable insights for novel treatments for
periodontitis.

1. Oral Mucosa and Gingival Epithelial Cell Lines
2. Cell Lines were exposed to LPS from P. gingivalis (LPSPG) and LPS from E. coli (LPS-EC) for 24 or 48 hours
3. Splenocytes from CD5KO and CD5 WT mice were
extracted and then extra T cells were co-cultured with the Oral
Mucosa and Gingival Epithelial Cell Lines
4. Differences in the T cell activation were measured after 24
hours and 48 hours by analyzing expression of CD69 and
CD25 activation markers by flow cytometry
5.RNA analysis/ELISpot Cytokine Assay
6.T cells were isolated from the splenocytes of CD5KO and
WT mice and stimulated with P. gingivalis for ELISpot plating
and cytokine antibody binding.

Figure 3: We measured differences in activation marker
expression using flow cytometry after oral mucosa and
gingival epithelial cell lines were exposed to P.
gingivalis-LPS and E.coli-LPS and co-cultured with T
cells from CD5KO and WT mice.
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Future Directions
We will further test our hypothesis by continuing our analysis of
cytokine production differences between WT and CD5KO T cells
by completing our last replicate.
Recent RNAseq data comparing transcriptome differences
between naive CD5KO and WT cells show increased transcription
of RANKL and M-CSF in CD5KO cells. In future experiments we
will also measure WT and CD5KO T cell RANKL production and
M-CSF, both contributing factors to osteoclast differentiation and
alveolar bone decay in CD5 periodontal disease.
Additionally we will measure T cell migration to better
understand the activation and immune response properties that
differ between WT and CD5KO T cells and to further investigate
the role of CD5 in the inflammatory response associated with
periodontal disease.

Conclusions
Characteristics of Periodontal Disease
Periodontal disease is a specific oral
inflammatory disease initiated by P. gingivalis, a
gram-negative bacterium that stimulates a
chronic immune response in the oral tissue [1].
Interactions between P. gingivalis bacteria and
oral mucosa and gingival epithelium cells lead to
the release of cytokines into the periodontal
pocket that recruit T cells to initiate an immune
response [2]. In the case of periodontal disease, T
cell function, differentiation, and proliferation
exaggerate the immune response and lead to an
increased inflammatory response and accelerated
bone decay.
Figure 1: In a 2009-2014 study done in the American population, data showed that half of
American adults 30 years or older suffered from a gum disease (mild, moderate, or severe
periodontitis) and that 7.8 percent of those cases were issues of severe periodontitis [3].
Periodontal disease also has a widespread presence globally. In 2016,the World Health
Organization (WHO) reported that over half of the global population suffered from oral
diseases caused by tobacco and/or poor oral hygiene [4,5].

CD5 plays a role in the inflammatory response associated with
periodontal disease

Figure 4: CD69, an early T cell activation marker, is
upregulated in CD5KO cells after 24 hours, This data
indicates that there is an increase in T cell activation in
CD5KO cells, supporting our hypothesis that T cell
activation is regulated by CD5.

Figure 5: CD25 an late T cell activation marker, is
upregulated in CD5KO cells after 48 hours, This data
indicates that there is an increase in T cell activation in
CD5KO cells, supporting our hypothesis that T cell
activation is regulated by CD5.

Cytokine Differences between CD5KO and WT T cells

Upregulation of CD69 and CD65T cell activation markers in
CD5KO T cells co-cultured with gingival and oral mucosal epithelial
cells and stimulated by P. gingivalis provide evidence that CD5 plays
a role in the chronic inflammation characteristic to periodontal
Disease. Preliminary inflammatory cytokine as well as RNA
sequencing and Bioinformaticss analysis show that cytokine
production could differ between CD5KO and WT T cells in
periodontal Disease. These findings support our hypothesis.
Our findings will help us to develop novel treatments and
avenues to mitigate and reduce the inflammatory immune response
and alveolar bone decay characteristic of periodontal disease.
Studies show that periodontal disease is also strongly correlated with
the presence of other severe chronic inflammatory conditions,
including cardiovascular disease, diabetes, and arthritis [7].
Although the exact mechanism of interaction between these similarly
characterized diseases is currently unclear, understanding more about
the pathogenesis of periodontal disease can help construct the
molecular narrative about chronic inflammatory disease and lead to
increased research opportunities and treatments.

T cell function and the CD5 Co-receptor
References
Our hypothesis is that T
cell activation is
regulated by CD5, which
affects the inflammatory
response and
pathogenesis of
periodontal disease.

Figure 2: T cell function is regulated and initiated by T cell signaling receptors (TCRs)
and co-receptors found on the surface of T cells that inhibit or enhance the T cell
immune response. CD5 is a co-receptor found on B cells and T cells. Previous studies
have shown that CD5 + B cells play a significant role in the overactive oral immune
response characteristic of periodontal disease and we aim to determine the role of CD5
in the pathogenesis of periodontal disease [6]. To our knowledge, no studies have been
performed to analyze the function of CD5 in the T cell immune response. We therefore
are seeking to characterize the role of CD5 in T cell activation and in the initiation of a
chronic inflammatory response.

Figure 6: RNA sequencing data shows that
inflammatory cytokines are upregulated in CD5KO
T cells. The next figure presents data from a
preliminary ELISpot assay to measure cytokine
production (IL-2, IL-17A, IFN-gamma, IL-10,
TGF-beta1, and IL-6) which are linked to
inflammation and periodontal disease as well as T
cell differentiation.
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Figure 7: Preliminary Data using two replicates.. CD5KO T
cells are shown to increase T cell activation even at basal level
in a periodontal environment. These pro-inflammatory and
anti-inflammatory cytokines are upregulated in comparison to
WT cells.
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